Abstract
MYOTONIC dystrophy (DM) is the most common form of adult muscular dystrophy, with a prevalence of 2–14 per 100,000 individuals1. The disease is characterized by progressive muscle weakness and sustained muscle contraction, often with a wide range of accompanying symptoms. The age at onset and severity of the disease show extreme variation, both within and between families. Despite its clinical variability, this dominant condition segregates as a single locus at chromosome 19ql3.3 in every population studied1. It is flanked by the tightly linked genetic markers ERCC1 proximally2,3 and D19S51 distally 4,5; these define the DM critical region. We report the isolation of an expressed sequence from this region which detects a DNA fragment that is larger in affected individuals than in normal siblings or unaffected controls. The size of this fragment varies between affected siblings, and increases in size through generations in parallel with increasing severity of the disease. We postulate that this unstable DNA sequence is the molecular feature that underlies DM.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Harper, P. S. Myotonic Dystrophy 2nd edn (Saunders, London and Philadelphia, 1989).
Smeets, H., Hermens, R., Brunner, H. G., Ropers, H.-H. & Wieringa, B. Genomics 9, 257–263 (1991).
Shutler, G. et al. Genomics 9, 500–504 (1991).
Johnson, K. et al. Am. J. hum. Genet. 46, 1073–1081 (1990).
Tsilfidis, C. et al. Am. J. hum. Genet. 49, 961–965 (1991).
Brunner, H. G. et al. Genomics 5, 589–595 (1989).
Johnson, K. et al. Genomics 5, 746–751 (1989).
Korneluk, R. et al. Genomics 5, 596–604 (1989).
Brook, J. D. et al. Cytogenet. Cell Genet. 41, 30–37 (1986).
Stallings, R. L. et al. Am. J. hum. Genet. 43, 144–151 (1988).
Schonk, D. et al. Genomics 4, 384–396 (1989).
Brook, J. D. et al. Genomics (in the press).
Smeets, H. et al. Am. J. hum. Genet. 46, 492–501 (1990).
Bird, A. P. Nature 321, 209–213 (1986).
C. Aslanidis et al. Nature, 355, 548–551 (1992).
Brook, J. D. et al. J. med. Genet. 28, 84–88 (1991).
Harley, H. G. et al. Am. J. hum. Genet. 49, 68–75 (1991).
Elvin, P. et al. Nucleic Acids Res. 18, 3913–3917 (1990).
Wallace, M. R. et al. Science 249, 181–186 (1990).
Oberle, I. et al. Science 252, 1097–1102 (1991).
Yu, S. et al. Science 252, 1179–1181 (1991).
La Spada, A. R., Wilson, E. M., Lubahn, D. B., Harding, A. E. & Fischbeck, K. H. Nature 352, 77–79 (1991).
Verkerk, A. J. M. H. et al. Cell 65, 905–914 (1991).
Fu, Y-H. et al. Cell 67, 1–20 (1991).
Howeler, C. J., Bush, H. F. M., Geraedts, J. P. M., Niermeijer, M. F. & Staal, A. Brain 12, 779–797 (1989).
Harley, H. G. et al. Nature 355, 545–546 (1992).
Koch, M. C., Grimm, T., Harley, H. G. & Harper, P. S. Am. J. hum. Genet. 48, 1084–1091 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Buxton, J., Shelbourne, P., Davies, J. et al. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 355, 547–548 (1992). https://doi.org/10.1038/355547a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/355547a0
- Springer Nature Limited
This article is cited by
-
Myotonic dystrophy type 1 as a major risk factor for severe COVID-19?
Acta Neurologica Belgica (2021)
-
Impact of prematurity and the CTG repeat length on outcomes in congenital myotonic dystrophy
BMC Research Notes (2020)
-
Noncoding CGG repeat expansions in neuronal intranuclear inclusion disease, oculopharyngodistal myopathy and an overlapping disease
Nature Genetics (2019)
-
Diversification of the muscle proteome through alternative splicing
Skeletal Muscle (2018)